The effect of transdermal nitroglycerin on pain control in diabetic patients with peripheral neuropathy

Journal of Diabetes and Metabolic Disorders

Volumn 14, Issue 1, 2015, Pages

  Taheri, Arman ^a   Farbood, Arash ^b,g,h   Heshmat, Ramin ^c   Samadi, Afshin ^a   Khashayar, Patricia ^d   Qorbani, Mostafa ^e   Ghorbani, Mohammad ^b   Ebrahimi Khaneqah, Ghazaleh ^f  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^g SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes complications; Nitroglycerin; Painful polyneuropathy

Indexed keywords

GLYCERYL TRINITRATE; PLACEBO;

ADULT; ARTICLE; BRIEF PAIN INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC PATIENT; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLYCEMIC CONTROL; HEADACHE; HUMAN; MALE; MCGILL PAIN QUESTIONNAIRE; MOOD; NAUSEA; NEUROPATHIC PAIN; PAIN SEVERITY; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; SLEEP; TRANSDERMAL PATCH; VERTIGO; VOMITING;

EID: 84959197756     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/s40200-015-0217-3     Document Type: Article

References (35)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4-14.
2. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patient observed between 1947 and 1973. Diabetes Care. 1978;1:168-88.
3. Fernandez VE, Abdi S. Painful diabetic peripheral neuropathy. In: Smith H, editor. Current therapy in pain. 1st ed. Philadelphia: Saunders; 2009. p. 250-5.
4. Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004;21:976-82.
5. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956-62.
6. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26:1790-5.
7. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ. 1995;311:1047-52.
8. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American academy of neurology, the American association of neuromuscular and electrodiagnostic medicine, and the American academy of physical medicine and rehabilitation. Neurology. 2011;76(20):1758-65.
9. McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain. 1996;68(2-3):217-27.
10. Dyck PJ, Zimmerman BR, Vilen TH. Nerve glucose, sorbitol, myoinositol and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med. 1988;319:542-8.
11. Cameron NE, Cotter MA, Ferguson K, Robertson S, Radcliffe MA. Effects of chronic adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na-K ATPase activity and vascular supply in stretozotocin-diabetic rats. Diabetes. 1991;40:1652-8.
12. Sasaki T, Yasuda H, Maeda K, Kikkawa R. Hyperalgesia and decreased neuronal nitric oxide synthase in diabetic rats. Neuroreport. 1998;9:243-7.
13. Rodella L, Rezzani R, Corsetti G, Bianchi R. Nitric oxide involvement in the trigeminal hyperalgesia in diabetic rats. Brain Res. 2000;865:112-5.
14. Pitei DL, Watkins PJ, Edmonds ME. NO-dependent smooth muscle vasodilatation is reduced in NIDDM patients with peripheral sensory neuropathy. Diabet Med. 1977;14:284-90.
15. Francis DR, Hubbard ER, Johnson LE. Nitroglycerin ointment as a vasodilator in the lower extremities. J Am Podiatry Assoc. 1977;67:874-9.
16. Coakley J. Nitroglycerin ointment for dopamine- induced peripheral ischaemia. Lancet. 1983;2:633.
17. Yuen KCJ, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray. Diabetes Care. 2002;25(10):1699-703.
18. Rayman G, Baker NR, Krishnan ST. Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy. Diabetes Care. 2003;26:2697-8.
19. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patient with non-insulin dependent diabetes mellitus. N Engl J Med. 1995;333:89-94.
20. Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, et al. A multicentre study on the prevalence of diabetic neuropathy in Italy. Diabetes Care. 1997;20:836-43.
21. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996;39:1377-84.
22. Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 1987;37:589-96.
23. Chakrabarti AK, Samantaray SK. Diabetic peripheral neuropathy: nerve conduction studies before, during and after carbamazepine therapy. Aust N Z J Med. 1976;6:565-8.
24. Boulton AJM, Gries FA, Jervell J. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med. 1998;15:917-31.
25. Kochar DK, Rawat N, Agrawal RP, Vyas A, Beniwal R, Kochar SK, et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM. 2004;97(1):33-8.
26. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA. 1998;280:1831-6.
27. Rice ASC, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double-blind, placebo controlled study. Pain. 2001;94:215-24.
28. Jones DL, Sorkin LS. Systemic gabapentin and S(+)-3-isobutyl-gammaaminobutyric acid block secondary hyperalgesia. Brain Res. 1998;81:93-9.
29. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology. 2004;63(11):2104-10.
30. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an "atypical" opioid analgesic. J Pharmacol ExpTher. 1992;260:275-85.
31. Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia. Anesthesiology. 2002;96(5):1053-61.
32. Goldsteina DJ, Lub Y, Detke MJ, Lee TC, Lyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116(1-2):109-18.
33. Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005;6(5):346-56.
34. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-9.
35. Gambito ED, Gonzalez-Suarez CB, Oquiňena TI, Agbayani RB. Evidence on the effectiveness of topical nitroglycerin in the treatment of tendinopathies: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2010;91:1291-305.